• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [267 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Stem cell therapy in heart failure prevention and progress
2016 HAYES, Inc. Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
2016 Technology Assessment Unit of the McGill University Health Centre (MUHC) Cardiac resynchronization therapy in heart failure
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sacubitril/valsartan - Benefit assessment according to §35a Social Code Book V]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sacubitril/valsartan: addendum to commission A15-60]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Measurement and monitoring of pulmonary artery pressure via an implanted sensor for treatment optimization in heart failure]
2016 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Measurement and monitoring of pulmonary artery pressure via an implanted sensor for treatment optimization in heart failure - Addendum to Commission E15-04]
2016 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Wireless technology for LV pacing without coronary sinus
2016 National Institute for Health and Care Excellence (NICE) Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction. NICE technology appraisal guidance 388
2016 Canary Health Service [Extracorporeal membrane oxygenation (ECMO) in patients with advanced heart failure or cardiogenic shock]
2015 NIHR Health Technology Assessment programme Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure
2015 NIHR Horizon Scanning Centre (NIHR HSC) Algisyl-LVR implantable hydrogel (biopolymer) for advanced heart failure
2015 Health Quality Ontario (HQO) Care coordination for postacute stroke, chronic obstructive pulmonary disease, and heart failure clients: an economic rapid review
2015 Health Quality Ontario (HQO) Care coordination on postacute stroke, chronic obstructive pulmonary disease, and heart failure clients: a rapid review
2015 Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review (update)
2015 Health Quality Ontario (HQO) Home-based exercise programs in heart failure: a rapid review
2015 Health Quality Ontario (HQO) Ultrafiltration in heart failure: a rapid review
2015 NIHR Health Technology Assessment programme Structured telephone support or telemonitoring programmes for patients with chronic heart failure
2015 Institute for Clinical Effectiveness and Health Policy (IECS) [Pro-BNP Peptide in the diagnosis and prognosis of heart failure]
2015 Agency for Healthcare Research and Quality (AHRQ) Use of cardiac resynchronization therapy in the Medicare population
2015 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficiency, effectiveness and safety of mechanical ventricular assistance with HeartWare® device in terminal heart failure]
2015 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) [Aquapheresis – ultrafiltartion for congestive heart failure]
2015 HAYES, Inc. Wireless pulmonary artery pressure monitoring with CardioMEMS HF System (St. Jude Medical) for management of chronic heart failure
2015 Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring multi-pathological chronic patients with heart or lung disease. Evaluation of the implementation in Primary Care]
2015 Adelaide Health Technology Assessment (AHTA) Ultra-filtration for patients with decompensated heart failure
2015 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "chronic heart failure"]
2015 National Institute for Health and Care Excellence (NICE) Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation. NICE interventional procedures guidance 516
2014 Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable cardiac resynchronization therapy and defibrillator (CRT-D) in patients with heart failure. Rapid HTA Report
2014 Agency for Healthcare Research and Quality (AHRQ) Transitional care interventions to prevent readmissions for people with heart failure
2014 NIHR Horizon Scanning Centre (NIHR HSC) Levosimendan (Leximda) for severe acute decompensated chronic heart failure – second line
2014 NIHR Horizon Scanning Centre (NIHR HSC) Wireless Cardiac Stimulation System for chronic heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra - Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014 Blue Cross Blue Shield Association (BCBS) Myocardial sympathetic innervation imaging in heart failure
2014 NIHR Health Technology Assessment programme Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation
2014 NIHR Horizon Scanning Centre (NIHR HSC) OPTIMIZER™ system for chronic heart failure
2014 Institut national d'excellence en sante et en services sociaux (INESSS) [Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014 NIHR Horizon Scanning Centre (NIHR HSC) CoVa™ Monitoring System for congestive heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone (Inspra — Pfizer Canada Inc.) new indication: NYHA class II heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014 Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable cardiac resyncronization therapy and defibrillator (CRT-D) in patient with heart failure
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for cardiac failure: a review of the clinical effectiveness and guidelines
2014 The Regional Health Technology Assessment Centre (HTA-centrum) Left Ventricular Assist Device as permanent support in patients with end-stage heart failure
2014 Basque Office for Health Technology Assessment (OSTEBA) [The development and piloting of a multidisciplinary collaborative program for the comprehensive care of patients diagnosed with heart failure (HF) – PROMIC]
2014 National Institute for Health and Care Excellence (NICE) Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure. NICE technology appraisal guidance 314
2014 National Institute for Health and Care Excellence (NICE) Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. NICE interventional procedures guidance 482
2014 Canary Health Service [Report on insertable Holter with remote monitoring]
2013 NIHR Health Technology Assessment programme Ivabradine for the treatment of chronic heart failure
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Parachute® Implant System for ischaemic heart failure
2013 NIHR Horizon Scanning Centre (NIHR HSC) LCZ696 for chronic heart failure – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) C-Pulse® Heart assist system for heart failure
2013 NIHR Horizon Scanning Centre (NIHR HSC) Revivent™ for heart failure with left ventricular scar
2013 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model
2013 Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of ventricular assist devices]
2013 Andalusian Health Technology Assessment Area (AETSA) [A review of indications for ventricular assist device therapy]
2013 Agency for Healthcare Research and Quality (AHRQ) Use of natriuretic peptide measurement in the management of heart failure
2013 Health Quality Ontario (HQO) Electrocardiograms for diagnosing ischemia as a precipitant to acute heart failure: a rapid review
2013 Health Quality Ontario (HQO) Vasodilators for inhospital heart failure management: a rapid review
2013 Health Quality Ontario (HQO) Early mobilization and ambulation in hospitalized heart failure patients:a rapid review
2013 Institute for Clinical and Economic Review (ICER) Cardiac nuclear imaging
2013 Basque Office for Health Technology Assessment (OSTEBA) [Economic evaluation of a telemonitoring intervention from primary care in home care patients with cardiac insufficiency and/or chronic bronchial disorders: Cost-effectiveness analysis, TELBIL study]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Evaluation and impact of a primary care-based telemonitoring intervention in home care patients with heart failure or chronic lung disease. Randomised controlled trial. The TELBIL study]
2013 Basque Office for Health Technology Assessment (OSTEBA) [Individualised multidisciplinary care programme in frail patients (PAMI)]
2012 NIHR Horizon Scanning Centre (NIHR HSC) Darbepoetin alfa (Aranesp) for anaemia in symptomatic heart failure
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) Adaptive servo ventilation versus continuous or bi-level positive airway pressure: a review of the clinical effectiveness, cost-effectiveness and guidelines
2012 Penn Medicine Center for Evidence-based Practice (CEP) Reducing heart failure readmissions
2012 NIHR Horizon Scanning Centre (NIHR HSC) Serelaxin for acute decompensated heart failure – in addition to IV diuretics
2012 Institut national d'excellence en sante et en services sociaux (INESSS) [Evaluation of the evidence on the HeartMate II and HeartWare ventricular assist devices for the treatment of chronic end-stage heart failure]
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ramipril 2.5 mg/5 ml oral solution
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eplerenone (Inspra) 25mg and 50mg film-coated tablets
2012 Andalusian Health Technology Assessment Area (AETSA) [Invasive telemonitoring in patients with heart failure]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Cost-effectiveness analysis of a telemonitoring experiment in patients with cardiac insufficiency and chronic obstructive pulmonary disease]
2012 Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring in patients with heart failure or chronic obstructive disease. Systematic review of the literature]
2012 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Tafamidis - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2012 National Institute for Health and Care Excellence (NICE) Ivabradine for treating chronic heart failure. NICE technology appraisal guidance 267
2011 HAYES, Inc. Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011 Penn Medicine Center for Evidence-based Practice (CEP) Telemedicine for patients with congestive heart failure
2011 Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of long-term ventricular assist devices (VADs) as a bridge-to-transplant in adults
2011 Institute for Clinical Effectiveness and Health Policy (IECS) [Pro-BNP peptide in the diagnosis and prognosis of heart failure]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Search for literature on angiotensin II antagonists and ACE inhibitors]
2011 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal for the DMP module on heart failure and extraction of new, relevant recommendations]
2011 Canary Health Service [Cost-effectiveness of implantable automatic defibrillator in primary prevention in Spain]
2011 Canary Health Service [Effectiveness and cost-effectiveness of implantable automatic defibrillators in Spain]
2010 HAYES, Inc. HeartMate II (Thoratec Corp.) Left Ventricular Assist Device (LVAD) for destination therapy in adult patients with chronic heart failure
2010 NIHR Horizon Scanning Centre (NIHR HSC) Tafamidis for transthyretin amyloid polyneuropathy
2010 Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive. Proposal for some changes in the Regeling eisen geschiktheid 2000
2010 Technology Assessment Unit of the McGill University Health Centre (MUHC) Efficacy, safety and cost of ultrafiltration for the management of acute decompensated heart failure
2010 Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of torsemide for edema in hospitalized heart failure patients
2010 Adelaide Health Technology Assessment (AHTA) Acoustic cardiography for the diagnosis of heart failure
2010 HAYES, Inc. Surgical ventricular restoration for heart failure
2010 HAYES, Inc. Ventricular Assist Devices (VADs) in children and adolescents with chronic, end-stage heart failure
2010 Haute Autorite de sante (HAS) [Cardiac markers in coronary disease and heart failure in outpatient medicine]
2009 The Netherlands Organisation for Health Research and Development (ZonMw) [The cost-effectiveness of NT-pro-brain natriuretic peptide (NT-proBNP) guided therapy of chronic heart failure]
2009 NIHR Health Technology Assessment programme Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
2009 The Netherlands Organisation for Health Research and Development (ZonMw) [High throughput and comprehensive resequencing of cardiomyopathy genes by CHIP based DNA-sequencing technology (CardioCHIP)]
2009 Blue Cross Blue Shield Association (BCBS) Cardiac resynchronization therapy for mild congestive heart failure
2009 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Rapid HTA on the use of natriuretic peptides for diagnosing cardiac insufficiency in patients with acute dyspnea]
2008 HAYES, Inc. Cardiac resynchronization therapy for heart failure
2008 VA Technology Assessment Program (VATAP) Ultrafiltration for heart failure
2008 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Continuous flow ventricular assist devices for bridge to transplantation